Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ABAHFOTCMKTS:ACGWFOTCMKTS:ACRGFOTCMKTS:CRTPF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABAHFAbacus Health Products$4.84-5.1%$4.84$1.12▼$8.40N/AN/A10,164 shs9,300 shsACGWFAlliance GrowersC$0.00C$0.00▼C$1.10N/AN/A6,184 shs2,966 shsACRGFAcreage$2.77$2.77$1.47▼$9.11N/AN/A340,301 shsN/ACRTPFCardiol Therapeutics$1.41-4.1%$1.20$1.48▼$4.19N/AN/A67,097 shs72,165 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABAHFAbacus Health Products0.00%0.00%0.00%0.00%0.00%ACGWFAlliance Growers0.00%0.00%0.00%0.00%0.00%ACRGFAcreage0.00%0.00%0.00%0.00%0.00%CRTPFCardiol Therapeutics0.00%+13.71%+12.80%+46.88%-30.20%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationABAHFAbacus Health ProductsN/AN/AN/AN/AN/AN/AN/AN/AACGWFAlliance GrowersN/AN/AN/AN/AN/AN/AN/AN/AACRGFAcreageN/AN/AN/AN/AN/AN/AN/AN/ACRTPFCardiol TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABAHFAbacus Health Products 0.00N/AN/AN/AACGWFAlliance Growers 0.00N/AN/AN/AACRGFAcreage 0.00N/AN/AN/ACRTPFCardiol Therapeutics 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABAHFAbacus Health ProductsN/AN/AN/AN/AN/AN/AACGWFAlliance GrowersN/AN/AN/AN/AN/AN/AACRGFAcreageN/AN/AN/AN/AN/AN/ACRTPFCardiol TherapeuticsN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABAHFAbacus Health ProductsN/AN/A0.00∞N/AN/AN/AN/AN/AACGWFAlliance GrowersN/AN/A0.00N/AN/AN/AN/AN/AN/AACRGFAcreageN/AN/A0.00∞N/AN/AN/AN/AN/ACRTPFCardiol TherapeuticsN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthABAHFAbacus Health ProductsN/AN/AN/AN/AN/AACGWFAlliance GrowersN/AN/AN/AN/AN/AACRGFAcreageN/AN/AN/AN/AN/ACRTPFCardiol TherapeuticsN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABAHFAbacus Health ProductsN/AACGWFAlliance GrowersN/AACRGFAcreageN/ACRTPFCardiol TherapeuticsN/AInsider OwnershipCompanyInsider OwnershipABAHFAbacus Health ProductsN/AACGWFAlliance GrowersN/AACRGFAcreageN/ACRTPFCardiol TherapeuticsN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABAHFAbacus Health Products29N/AN/ANot OptionableACGWFAlliance GrowersN/AN/AN/ANot OptionableACRGFAcreage1,090N/AN/ANot OptionableCRTPFCardiol Therapeutics20N/AN/ANot OptionableCRTPF, ABAHF, ACRGF, and ACGWF HeadlinesRecent News About These CompaniesCardiol Therapeutics management to meet with OppenheimerApril 2, 2025 | msn.comCardiol Therapeutics Inc.: Cardiol Therapeutics to Present at TD Cowen 45th Annual Health Care ConferenceMarch 3, 2025 | finanznachrichten.deCardiol Therapeutics’ CardiolRx Gains Buy Rating on Positive Phase 2 Results and Strong Financial PositionNovember 20, 2024 | markets.businessinsider.comCardiol To Advance CardiolRx To Phase III Trial Following Positive ResultsNovember 19, 2024 | thedeepdive.caTCardiol Therapeutics Faces Rising Losses and Falling AssetsNovember 15, 2024 | markets.businessinsider.comInside the production pipeline for new drugs to combat heart failureSeptember 14, 2024 | msn.comCardiol Therapeutics: First-Mover In CBD-Based Treatment For Heart DiseaseAugust 22, 2024 | seekingalpha.comWill Earnings Beat Estimates? Cardiol Therapeutics Inc (CRDL) StockMay 16, 2024 | bovnews.comBCardiol Therapeutics Granted Orphan Drug Designation for its Lead Drug Candidate for the Treatment of PericarditisFebruary 15, 2024 | finance.yahoo.comCardiol Therapeutics Fights Heart Inflammation With Novel FormulationsOctober 12, 2023 | benzinga.comCardiol Therapeutics Inc. (CRDL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?September 13, 2023 | finance.yahoo.comClosing Bell: Cardiol Therapeutics Inc flat on Friday (CRDL)August 26, 2023 | theglobeandmail.comCardiol Therapeutics: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (CRDL)August 18, 2023 | theglobeandmail.comClosing Bell: Cardiol Therapeutics Inc flat on Monday (CRDL)August 14, 2023 | theglobeandmail.comCardiol Therapeutics Regains Compliance with all Applicable Listing Standards of The Nasdaq Capital MarketAugust 8, 2023 | finance.yahoo.comClosing Bell: Cardiol Therapeutics Inc up on Thursday (CRDL)April 20, 2023 | theglobeandmail.comCardiol Therapeutics Announces Study Results from Collaborating Research Center Demonstrating…March 7, 2023 | technical420.comTCardiol Therapeutics Announces First Patient Enrolled in Phase II Study Evaluating CardiolRx(TM) for the Treatment of Recurrent PericarditisJanuary 17, 2023 | investorintel.comICardiol Therapeutics Commences Multi-center Phase II Pilot Study of CardiolRx™ for the Treatment of Recurrent PericarditisDecember 12, 2022 | technical420.comTHere's Why Cardiol Therapeutics Inc. (CRDL) Could be Great Choice for a Bottom FisherNovember 11, 2022 | nasdaq.comNew MarketBeat Followers Over TimeCRTPF, ABAHF, ACRGF, and ACGWF Company DescriptionsAbacus Health Products OTCMKTS:ABAHF$4.84 -0.26 (-5.10%) As of 06/11/2020Abacus Health Products, Inc. manufactures and sells over-the-counter (OTC) topical formulations infused with cannabidiol (CBD) extracted from hemps. The company offers CBD CLINIC line of products for relief from acute musculoskeletal and joint pain, which includes analgesic ointments, creams, and pain sticks, as well as analgesic massage oils. It also provides CBDMEDIC line of products, such as sport ointments and pain sticks, back and neck ointments, arthritis hand creams and ointments, and massage therapy oils, as well as ointments and pain sprays for muscles and joints. The company offers its CBD CLINIC products to registered health practitioners, including chiropractors, acupuncturists, massage and physical therapists, naturopaths, and osteopaths; and CBDMEDIC products directly to consumers through retail pharmacy chains and fitness locations, as well as online through the e-commerce platform. In addition, it is involved in developing a pipeline of other OTC CBD products addressing additional medical indications and the health and wellness sectors. The company is headquartered in Toronto, Canada. Abacus Health Products, Inc. is a subsidiary of Aidance Skincare & Topical Solutions, LLC.Alliance Growers OTCMKTS:ACGWFAlliance Growers Corp. engages in acquiring investments in and developing projects in the medical cannabis sector in British Columbia. The company is headquartered in Vancouver, Canada.Acreage OTCMKTS:ACRGF$2.77 0.00 (0.00%) As of 09/30/2020Acreage Holdings, Inc. engages in owning and operating cannabis licenses and assets in the U.S. with respect to the number of states with cannabis related licenses. It focuses on the cultivation, processing, and distribution operations. The company was founded by Kevin P. Murphy on July 12, 1989 and is headquartered in New York, NY.Cardiol Therapeutics OTCMKTS:CRTPF$1.41 -0.06 (-4.08%) As of 06/27/2025Cardiol Therapeutics Inc. is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus. The company was founded by David Elsley, Eldon Smith, and Anthony Bolton on January 19, 2017 and is headquartered in Oakville, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Snowflake Hits 52-Week High—Options Traders Bet on Further Rally Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
